Dogwood Therapeutics, Inc. (DWTX)
$1.30-5.11%Close
SELLCRISIS · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.94
- P/E (TTM)
- -0.15
- Short % float
- 2.87%
- Days to cover
- 1.0
- SI change
- -47.6%
- 1W
- -14.47%
- 1M
- -29.73%
- vs SPY 1W
- -14.34%
- vs SPY 1M
- -32.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on DWTX?
- LOPJLB’s latest quantitative signal on Dogwood Therapeutics, Inc. (DWTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is DWTX in?
- Dogwood Therapeutics, Inc. (DWTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Dogwood Therapeutics, Inc. (DWTX) do?
- Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the compan…